Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-063948

Director acquired 100,699 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ebeling Thomas Director 2024-05-23 Grant or award +84,224 $4.30 $362,163 151,728 D: show line 1 in the form
Ebeling Thomas Director 2024-05-23 Grant or award +16,475 $12.73 $209,727 168,203 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ebeling Thomas Director 2024-05-23 Option exercise · Stock Option (Right to Buy) −84,224 0 D: show line 3 in the form
Ebeling Thomas Director 2024-05-23 Option exercise · Stock Option (Right to Buy) −16,475 0 D: show line 4 in the form
Loading xslF345X05/ownership.xml…